Annual Cash & Cash Equivalents:
$71.62M+$4.17M(+6.19%)Summary
- As of today, XERS annual cash & cash equivalents is $71.62 million, with the most recent change of +$4.17 million (+6.19%) on December 31, 2024.
- During the last 3 years, XERS annual cash & cash equivalents has risen by +$4.35 million (+6.47%).
- XERS annual cash & cash equivalents is now -41.28% below its all-time high of $121.97 million, reached on December 31, 2022.
Performance
XERS Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$91.60M+$32.31M(+54.50%)Summary
- As of today, XERS quarterly cash & cash equivalents is $91.60 million, with the most recent change of +$32.31 million (+54.50%) on September 30, 2025.
- Over the past year, XERS quarterly cash & cash equivalents has increased by +$22.20 million (+31.98%).
- XERS quarterly cash & cash equivalents is now -36.39% below its all-time high of $144.00 million, reached on June 30, 2020.
Performance
XERS Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
XERS Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +6.2% | +32.0% |
| 3Y3 Years | +6.5% | -2.0% |
| 5Y5 Years | +266.9% | -35.4% |
XERS Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -41.3% | +6.5% | -24.9% | +56.7% |
| 5Y | 5-Year | -41.3% | +266.9% | -35.4% | +56.7% |
| All-Time | All-Time | -41.3% | +266.9% | -36.4% | +117.9% |
XERS Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $91.60M(+54.5%) |
| Jun 2025 | - | $59.28M(+1.4%) |
| Mar 2025 | - | $58.44M(-18.4%) |
| Dec 2024 | $71.62M(+6.2%) | $71.62M(+3.2%) |
| Sep 2024 | - | $69.40M(-10.5%) |
| Jun 2024 | - | $77.57M(-11.2%) |
| Mar 2024 | - | $87.35M(+20.6%) |
| Dec 2023 | $67.45M(-44.7%) | $72.45M(+9.8%) |
| Sep 2023 | - | $65.97M(-18.2%) |
| Jun 2023 | - | $80.67M(-15.2%) |
| Mar 2023 | - | $95.10M(-22.0%) |
| Dec 2022 | $121.97M(+81.3%) | $121.97M(+30.5%) |
| Sep 2022 | - | $93.43M(-16.2%) |
| Jun 2022 | - | $111.55M(-15.6%) |
| Mar 2022 | - | $132.15M(+29.0%) |
| Dec 2021 | $67.27M | $102.43M(+10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $92.98M(-19.8%) |
| Jun 2021 | - | $115.98M(-14.7%) |
| Mar 2021 | - | $135.89M(+1.6%) |
| Dec 2020 | $37.60M(+92.6%) | $133.79M(-5.6%) |
| Sep 2020 | - | $141.74M(-1.6%) |
| Jun 2020 | - | $144.00M(+48.5%) |
| Mar 2020 | - | $96.94M(+28.3%) |
| Dec 2019 | $19.52M(-57.3%) | $75.55M(+34.5%) |
| Sep 2019 | - | $56.16M(-15.8%) |
| Jun 2019 | - | $66.67M(+7.6%) |
| Mar 2019 | - | $61.98M(+35.6%) |
| Dec 2018 | $45.72M(+8.7%) | $45.72M(-39.6%) |
| Sep 2018 | - | $75.75M(-43.7%) |
| Jun 2018 | - | $134.53M(+131.5%) |
| Mar 2018 | - | $58.11M(+38.2%) |
| Dec 2017 | $42.05M(+30.3%) | $42.05M |
| Dec 2016 | $32.27M | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual cash & cash equivalents year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly cash & cash equivalents year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of XERS is $71.62M
What is the all-time high annual cash & cash equivalents for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual cash & cash equivalents is $121.97M
What is Xeris Biopharma Holdings, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, XERS annual cash & cash equivalents has changed by +$4.17M (+6.19%)
What is Xeris Biopharma Holdings, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of XERS is $91.60M
What is the all-time high quarterly cash & cash equivalents for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly cash & cash equivalents is $144.00M
What is Xeris Biopharma Holdings, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, XERS quarterly cash & cash equivalents has changed by +$22.20M (+31.98%)